Used in pharmaceutical research as a potential histamine H3 receptor antagonist. Shows promise in the development of drugs targeting neurological disorders such as Alzheimer's disease, schizophrenia, and attention deficit hyperactivity disorder (ADHD). Its structure allows for high selectivity and binding affinity to H3 receptors, which play a key role in regulating neurotransmitter release in the central nervous system. Also investigated for anti-inflammatory and analgesic properties due to its ability to modulate central and peripheral pain pathways. Serves as a lead compound in medicinal chemistry for optimizing pharmacokinetic and pharmacodynamic profiles in CNS-active agents.